Logical model of the HIQA Draft National Standard for Electronic Prescriptions and Electronic Dispensations, v1.1 draft for public consultation, September 2026. Built only from the element IDs, conformance, cardinality and datatypes published in the draft. Coded values are not specified by HIQA. This is a consultation draft and will change. Not endorsed by HIQA.

The patient's allergy and intolerance statement sent with an ePrescription (HIQA EP 1.6.1 / 1.6.2). Either it lists the allergies (entry → IEMpdAllergyIntolerance), or it states why none are recorded (emptyReason: e.g. nilknown = no known allergies, notasked, unavailable). A prescription cannot be sent without one, so a pharmacist can always tell 'no known allergies' from 'not asked' (clinical-safety hazard IE Core HZ-03).

The IE Medication Events AllergyIntolerance profile sets minimum expectations for the AllergyIntolerance resource to record, search, and fetch allergy and intolerance data associated with a patient, based on Irish requirements.

Records body height/length observations in the Irish healthcare context. Accepted UCUM units: [in_i] (inches) or cm (centimetres).

Records body weight observations in the Irish healthcare context. Accepted UCUM units: [lb_av] (pounds) or kg (kilograms).

An Electronic Prescription Group (ePG): a Bundle of one or more electronic prescriptions (eP, IEMpdMedicationRequestEPrescription) issued together as part of the same request, sharing one prescription group identifier (MedicationRequest.groupIdentifier), with the eDispensations of those eP (IEMpdMedicationDispenseEDispensation) and their provenance (the prescriber's signature, dispensing records). The prescription group header (IEMpdPrescriptionGroupHeader) carries the group-level data HIQA EP Section 3 defines (identifier, date of issue, status, presented form), because a Bundle cannot. The patient (IEMpdPatientEPrescription), prescriber and facility, dispensing pharmacist and pharmacy, medicinal products and the allergy statement (IEMpdListAllergiesAtPrescribing) travel with them. Prescription-level legal and safety rules (HIQA EP 1.4.2, 1.6.1, 2.9, 2.10.1, 3.1 to 3.5, 6.5) are enforced here because they span resources.

An ePrescription issued in Ireland to be dispensed in another EU Member State, or issued in another Member State to be dispensed in Ireland. A sender (NePS or the National Contact Point for eHealth) marks a cross-border prescription by claiming this profile in Bundle.meta.profile. No invented tag is used (IE Core ADR-003). It adds the legal requirements HIQA cites for cross-border prescriptions: patient date of birth (EP 1.4.1), prescriber telephone and secure email (EP 2.10.1, 2.10.2), and an electronic signature (EP 2.13).

The IE Medication Events Location Profile is based upon the core FHIR Location Resource and defines the minimum set of data required to query and retrieve location information within the Irish healthcare system. It covers details such as the location name, type, address, and managing organization.

The medicinal product in an Irish ePrescription or eDispensation (HIQA EP Section 4), derived from the HL7 Europe MPD Medication. Many elements are expected to be auto-populated from the National Medicinal Product Catalogue (NMPC).

A medicine given to, or taken by, a patient under observation: a dose administered in hospital, a GP practice, a pharmacy or the community, or a dose that was due but not given. IE-defined (HIQA's EP draft does not cover administration). Not-given doses state the reason (invariant ie-mad-status-1); given doses record what was given (ie-mad-dose-1).

The IE Medication Events MedicationDispense profile sets minimum expectations for the MedicationDispense resource to record, search, and fetch medication dispensing events associated with a patient, based on Irish requirements.

An Irish electronic dispensation record (HIQA EP Section 6), derived from the HL7 Europe MPD MedicationDispense. Covers a completed dispense, a partial or instalment dispense, and a non-dispensation (declined or stopped, with a reason).

An Irish electronic prescription (eP): one prescribed medication (HIQA EP 3.5 prescription item), derived from the HL7 Europe MPD MedicationRequest. One or more eP issued together as part of the same request form an Electronic Prescription Group (IEMpdElectronicPrescriptionGroup): they share the prescription group identifier in groupIdentifier and are exchanged with the patient, prescriber, facility, allergy statement, eDispensations and provenance.

What a patient is taking, has taken or will take, as reported by the patient, a carer or a clinician (a medication use statement), derived from the HL7 Europe Base MedicationStatement (medicationStatement-eu-core). Traced to the HIQA draft Patient Summary Section 6.3 (Medication). Aligned with the Xt-EHR EHDSMedicationUse logical model v1.0.0; the R5 equivalent is MedicationUsage.

The IE Medication Events Organization Profile is based upon the core FHIR Organization Resource and defines the minimum set of data required to query and retrieve organization information within the Irish healthcare system. Identifier slicing for HIQA-sourced facility identifiers is defined in the use-case context (HIQA EP/PS 2.8, 2.12).

Base Patient profile for the Irish health system, derived from the HL7 Europe Base Patient. It is deliberately permissive: special-category and identity-disambiguation data (for example ethnicity or mother's maiden name) are allowed but NOT MustSupport. Use-case profiles decide what must be sent and what must not be sent: IEMpdPatientEPrescription for ePrescription and eDispensation, and IEMpdPatientSummaryPatient for the Patient Summary (IE Core ADR-002, GDPR Art. 5(1)(c) data minimisation).

The patient as the subject of an ePrescription or eDispensation. It carries the HIQA ePrescription/eDispensation patient dataset (Section 1) and nothing more. Ethnicity, mother's maiden name, nationality, citizenship, place of birth, religion, marital status, pronouns, photo and contact persons are not part of that dataset, so they are prohibited (GDPR Art. 5(1)(c) data minimisation; ethnicity and religion are Art. 9 special-category data). Patient identity is established by the IHI (when available) together with name, date of birth and address (see the clinical-safety log, IE Core HZ-06).

The IE Medication Events Practitioner Profile is based upon the core FHIR Practitioner Resource and defines the minimum set of data required to query and retrieve practitioner demographic information within the Irish healthcare system. It includes identifier slicing for professional registration numbers (HIQA EP/PS 2.6).

The IE Medication Events PractitionerRole Profile is based upon the core FHIR PractitionerRole Resource and defines the minimum set of data required to query and retrieve practitioner role information within the Irish healthcare system. It constrains references to IE Medication Events profiles and binds the role code to the IE Medication Events Healthcare Provider Taxonomy.

The header of an Electronic Prescription Group (ePG): the group-level data HIQA EP Section 3 defines, which a Bundle cannot carry: the prescription group identifier (3.1), date and time of issue (3.2), prescription group status with reason (3.3), presented form (3.4), and the electronic prescriptions (eP) it groups (3.5, one action per MedicationRequest). One entry of the ePG Bundle (IEMpdElectronicPrescriptionGroup, ADR-003).

The IE Medication Events Provenance profile sets minimum expectations for the Provenance resource to record, search, and fetch provenance information associated with a record, based on Irish requirements.

The prescriber's electronic signature over the electronic prescriptions (eP) (HIQA EP 2.13 Signature). A Provenance signature is used rather than Bundle.signature so that the signature survives storage in NePS and re-bundling for cross-border exchange (IE Core ADR-003). The signature format and eIDAS assurance level are Requires Clarification (IE Core OI-009).

The IE Medication Events RelatedPerson profile sets minimum expectations for the RelatedPerson resource to record, search, and fetch related person data associated with a patient, based on Irish requirements.

Base vital signs profile for the Irish healthcare context. Inherits from the FHIR Vital Signs base profile.

How a medicine is to be taken or given (HIQA EP Section 5 Dosaging). Used by the ePrescription item, the eDispensation and the medication statement. Structured dosage always comes with human-readable text, a frequency always has its period, and doses use SNOMED CT units of presentation or UCUM. See the Dosage guidance page.

HIQA PS 1.4.8 Country of affiliation (Required 0..1): the designated source country where the patient and their health information are based. Typically, but not always, the country of residence, and it may differ from nationality. No HL7 extension exists. Patient Summary only; prohibited in ePrescription (IE Core ADR-002).

HIQA EP 6.4.3 Related person is the receiver (Optional): the person (e.g. carer or family member) who collected the dispensed medication on the patient's behalf. R4 MedicationDispense.receiver allows only Patient or Practitioner.

HIQA EP 3.5.9.2 'Do Not Extend' (Optional 0..1): true when the prescriber does not want the pharmacist to extend the prescription beyond its validity period. HIQA: pharmacists can extend a six-month prescription for up to a further six months.

A patient's ethnicity (repeat the extension for more than one ethnic background). GDPR Art. 9 special-category data. HIQA PS 1.4.10 (Required 0..*, coded). It is NOT part of the HIQA ePrescription/eDispensation dataset and is prohibited in IEMpdPatientEPrescription (IE Core ADR-002). HIQA: 'not used for patient identification'; collected with appropriate safeguards and consent.

HIQA EP 4.11 Exempt medication item (Required 0..1, Boolean, expected auto-populated). REQUIRES CLARIFICATION: the draft does not say what the item is exempt from (e.g. an exempt medicinal product without a marketing authorisation). Modelled as a boolean flag so that the dataset element can be carried; see the open issues.

HIQA EP 3.5.10.1 (Required 0..1, expected auto-populated from the NMPC): whether the medicinal product is on the HPRA List of Interchangeable Medicines. If true, substitution is allowed by default unless the prescriber invokes 'Do Not Substitute' (MedicationRequest.substitution.allowedBoolean = false).

One former surname of the patient's mother (repeat for each). HIQA PS 1.4.6 'Mother's former surnames' (Required 0..*): all former surnames of the patient's mother that may help identify the patient. The HL7 patient-mothersMaidenName extension holds only one name. Whether HIQA means the mother's birth surname only is Requires Clarification (IE Core OI-011). Patient Summary only; prohibited in ePrescription (IE Core ADR-002).

HIQA EP 3.5.12 Number of instalments (Required 0..1): whether the total quantity can be dispensed in smaller, specified amounts at specified intervals (phased dispensing). This differs from repeats (numberOfRepeatsAllowed, EP 3.5.11). HIQA: a legal requirement for Schedule 2, 3 and 4 Part 1 controlled drugs; the interval is dispenseRequest.dispenseInterval (EP 3.5.13).

HIQA EP 1.4.2 Age (cluster): the patient's age recorded on the prescription. HIQA: if the date of birth shows the patient is under 12 years, recording the age on the prescription record is a legal requirement in Ireland. Age should be entered in years, and to the nearest three months (or less) for children under two. 1.4.2.1 value and 1.4.2.2 type are Mandatory within the cluster.

Why the electronic prescription as a whole has its status, e.g. why it was cancelled (HIQA EP 3.3.2 coded reason; 3.3.3 free text in CodeableConcept.text). The R4 RequestGroup has no statusReason element, and the core request-statusReason extension does not allow RequestGroup.

A rendered copy of the electronic prescription as presented to people, such as a PDF (HIQA EP 3.4 Presented form, Optional).

HIQA EP 3.5.7.2 Quantity prescribed (free text): the overall quantity in words and figures, e.g. 'twenty-eight (28) tablets'. HIQA: a legal requirement if the item is a controlled drug under the Misuse of Drugs Act 1977 (as amended) and the Misuse of Drugs Regulations 2017 (S.I. No. 173/2017). Enforced for MDA Schedules 2, 3 and 4 Part 1 by invariant ie-rx-cd-1.

UCUM units for recording a patient's age: years, months or days (HIQA EP 1.4.2.2).

Codes for substances and clinical findings related to allergies and intolerances, from the SNOMED CT Irish Edition (module 1601000220105). Not expandable on tx.fhir.org, which does not host the Irish Edition (OI-022).

Ethnic group/background per the CSO Data Standard for Ethnicity v1.0 (7 Feb 2025). HIQA PS 1.4.10 only (GDPR Art. 9); prohibited in ePrescription (IE Core ADR-002). Grouping codes (white, black, asian, arab, mixed, other) SHOULD NOT be used when a specific category is known.

Healthcare provider taxonomy codes for categorising provider specialties and roles.

Medication codes for the Irish healthcare system. NMPC (via the SNOMED CT Irish Edition hosted on the HSE Central Terminology Server) is the preferred primary medication code wherever available. SNOMED CT Irish Edition is the preferred secondary clinical terminology wherever available, and ATC (WHO) codes are included for international classification and EU cross-border interoperability (EHDS/MyHealth@EU). Query the HSE CTS with system http://snomed.info/sct and version http://snomed.info/sct/1601000220105 (the SNOMED CT Irish Edition) for real medication codes.

PLACEHOLDER. Controlled drug schedules (S.I. No. 173/2017). HIQA EP 4.2.3. Requires Clarification (IE Core OI-007).

PLACEHOLDER. PCRS scheme number types (HIQA EP/PS 1.3.3.1 examples). Requires Clarification (IE Core OI-007).

Provenance participant type codes including IE Medication Events specific types.

The 26 counties of the Republic of Ireland.

Codes representing the 26 counties of the Republic of Ireland.

Ethnic group/background categories and codes of the Central Statistics Office (CSO) Data Standard for Ethnicity, version 1.0 (released 7 February 2025): https://www.cso.ie/en/methods/classifications/csodatastandardsandclassifications/csodatastandards/csodatastandardforethnicity/ . Codes and category names are the CSO's; groupings (White, Black, Asian, Arab, Mixed, Other) are expressed as a hierarchy. Open categories ('please specify') carry the patient's own description in CodeableConcept.text. GDPR Art. 9 special-category data: used only in the Patient Summary (HIQA PS 1.4.10), never in ePrescription/eDispensation (IE Core ADR-002). This IE Medication Events representation will be replaced if the CSO publishes a FHIR CodeSystem.

PLACEHOLDER. Controlled drug schedules of the Misuse of Drugs Regulations 2017 (S.I. No. 173/2017), cited by HIQA EP 4.2.3 (MDA Schedule, Required, expected auto-populated from the NMPC). The schedule names come from the regulations; the codes are IE Medication Events placeholders. Requires Clarification (IE Core OI-007): to be replaced by the NMPC/HPRA representation.

PLACEHOLDER. Types of Primary Care Reimbursement Service (PCRS) scheme number, taken from the examples in HIQA EP/PS 1.3.3.1: medical card scheme, GP visit card, Drugs Payment Scheme (DPS), Long-Term Illness scheme and Health Amendment Act card scheme (HAA). Used as Identifier.type for HIQA 'other identifiers used in health and social care'. Requires Clarification (IE Core OI-007): to be replaced by an HSE/PCRS code system.

Codes for provenance participant types specific to the IE Medication Events Implementation Guide.

PLACEHOLDER. Legal supply status of a medicinal product, HIQA EP 4.2.2 (Required, auto-populated). Only the two statuses given as examples in the HIQA text are included. Requires Clarification (IE Core OI-007): to be replaced by the NMPC/HPRA representation.

PLACEHOLDER URI, pending a URI published by the issuing authority (Requires Clarification, IE Core OI-003). HIQA EP definitions (dentist prescribers).

PLACEHOLDER URI, pending a URI published by the issuing authority (Requires Clarification, IE Core OI-003). HIQA EP/PS 2.12.

PLACEHOLDER URI in IE Core's namespace (ADR-001), pending a URI published by the issuing authority (IE Core OI-003). The health services provider identifier (HSPI) of an individual provider: Health Identifiers Act 2014 s.13 (assignment, 'a unique number', alphanumeric) and s.14 (National Register of Health Services Provider Identifiers, Parts A health practitioners, C relevant employees, D individual relevant agents). No format is set by the Act, so none is enforced. Whether individual and organisation HSPIs share one number range is Requires Clarification (OI-030).

PLACEHOLDER URI in IE Core's namespace (ADR-001), pending a URI published by the issuing authority (IE Core OI-003). The health services provider identifier (HSPI) of an organisation provider, such as a hospital, GP practice or pharmacy: Health Identifiers Act 2014 s.13 (assignment, 'a unique number', alphanumeric) and s.14 (National Register of Health Services Provider Identifiers, Parts B relevant bodies, E corporate relevant agents). No format is set by the Act, so none is enforced. Whether individual and organisation HSPIs share one number range is Requires Clarification (OI-030).

PLACEHOLDER URI, pending a URI published by the issuing authority (Requires Clarification, IE Core OI-003). HIQA EP/PS 1.3.1. Issued by the HSE; 18 or 10 digits.

PLACEHOLDER URI, pending a URI published by the issuing authority (Requires Clarification, IE Core OI-003). HIQA EP/PS 2.6.2.

PLACEHOLDER URI, pending a URI published by the issuing authority (Requires Clarification, IE Core OI-003). HIQA EP 3.1: the NePS electronic prescription (group) identifier used throughout the prescription and dispensation life cycle.

PLACEHOLDER URI, pending a URI published by the issuing authority (Requires Clarification, IE Core OI-003). HIQA EP/PS 2.6.2 (RNP/RMP divisions).

PLACEHOLDER URI, pending a URI published by the issuing authority (Requires Clarification, IE Core OI-003). HIQA EP/PS 1.3.3.1 example. No format enforced.

PLACEHOLDER URI, pending a URI published by the issuing authority (Requires Clarification, IE Core OI-003). HIQA EP/PS 1.3.3.1 example (Health Amendment Act card scheme). No format enforced.

PLACEHOLDER URI, pending a URI published by the issuing authority (Requires Clarification, IE Core OI-003). HIQA EP/PS 1.3.3.1 example. No format enforced.

PLACEHOLDER URI, pending a URI published by the issuing authority (Requires Clarification, IE Core OI-003). HIQA EP/PS 1.3.3.1 lists it as an example of an other identifier. HIQA gives no format, so none is enforced (IE Core ADR-006).

PLACEHOLDER URI, pending a URI published by the issuing authority (Requires Clarification, IE Core OI-003). HIQA EP/PS 2.8.

PLACEHOLDER URI, pending a URI published by the issuing authority (Requires Clarification, IE Core OI-003). HIQA EP/PS 1.3.2. Use as a health identifier is Requires Clarification (IE Core OI-008).

PLACEHOLDER URI, pending a URI published by the issuing authority (Requires Clarification, IE Core OI-003). HIQA EP/PS 2.6.2: up to eight digits.

CRITICAL ALLERGY: Seán Murphy has a documented severe anaphylactic reaction to Penicillin and Amoxicillin (penicillin-class antibiotics). First documented 1995. Do NOT dispense penicillin-class antibiotics.

Essential Hypertension (ICD-10: I10 / SNOMED: 38341003). Active since 2019. Managed with Lisinopril 10mg.

Hypercholesterolaemia (ICD-10: E78.0 / SNOMED: 13644009). Active since 2020. Managed with Atorvastatin 20mg.

Type 2 Diabetes Mellitus (ICD-10: E11 / SNOMED: 44054006). Active since 2018. Managed with Metformin 500mg.

1 to 2 actuations when needed (HIQA EP 5.2.5 as needed: a boolean, because HL7 Europe MPD allows only asNeededBoolean, so the reason is in the text; 5.2.3.1.2 dose range), at most 8 actuations in 24 hours (ie-dos-3).

Three dosages that apply at the same time share sequence 1: 6 units before breakfast, 4 before lunch, 8 before the evening meal (HIQA EP 5.2.4.6 event: ACM, ACD, ACV). Strength-based dose in UCUM international units.

Four tablets once a week on Mondays (HIQA EP 5.2.4.4 day of the week; frequency 1 per 1 week). A high-risk weekly medicine: the patient instruction states the day. The medicine is given as text only because its NMPC code has not been verified in the NMPC Meds Catalogue for this IG.

HIQA EP 1.6.2: the allergy statement lists the recorded allergies.

HIQA EP 1.6.1.

HIQA EP 1.6.1, confirmed with the child's parent at the consultation.

HIQA EP 1.6.1: no allergies recorded because the patient has none known (nilknown), which is different from 'not asked'.

HIQA EP 1.6.2 / PS 5.3: confirmed penicillin allergy with anaphylaxis.

Paediatric oral suspension (scenario 2).

International SNOMED CT product code and the NMPC VMP (SNOMED CT Irish Edition, verified in the NMPC Meds Catalogue); ATC classification and supply legal status (HIQA EP 4.2).

Fictional community pharmacy with a PSI Retail Pharmacy Business registration number (HIQA EP 2.8).

Adult patient for scenarios 4 (controlled drug) and 6 (cross-border).

Fictional general practitioner, the prescriber in the HIQA scenarios (HIQA EP Section 2).

The prescriber's role and contact details (HIQA EP 2.5, 2.10.1 telephone, 2.10.2 secure email).

Fictional registered pharmacist with a PSI registration number (HIQA EP 2.6.2).

Adult patient for scenarios 3 (repeat) and 5 (non-dispensation).

Paediatric patient for scenario 2. Under 12 at the date of prescribing, so the prescription must state the age (HIQA EP 1.4.2).

Controlled drug (scenario 4). The MDA schedule (HIQA EP 4.2.3) uses the IEMpdMDASchedule placeholder code system (Requires Clarification, IE Core OI-007); it drives invariants ie-rx-cd-1 and ie-rx-cd-2.

Fictional GP practice: the prescriber's facility (HIQA EP 2.7–2.12), with a GMS Panel ID (EP 2.12).

Repeat medication (scenarios 3 and 7). SNOMED CT uses the USAN name albuterol.

Adult patient for scenario 1 (acute prescription). Only the HIQA EP Section 1 dataset: no ethnicity, nationality or mother's maiden name.

An example IE Core Encounter representing a completed ambulatory consultation at St. James's Hospital.

An example IE Core Location representing the GP Clinic at St. James's Hospital.

An example IE Core Organization representing St. James's Hospital, Dublin — a major acute hospital under the HSE.

An example IE Core Patient representing a male adult living in Dublin with an IHI and a medical card number; conforms to the HIQA ePrescription patient dataset.

An example IE Core Practitioner representing a General Practitioner with IMC registration and HPI identifier.

An example Irish registered pharmacist dispensing medication in Dublin.

An Irish patient with a chronic prescription for Amlodipine who is visiting Spain and seeks dispensation at a Spanish pharmacy via MyHealth@EU.

An example Irish community pharmacy (Boots Pharmacy, Dublin), acting as dispenser.

Amlodipine 5mg tablets (generic), coded with the NMPC VMP (SNOMED CT Irish Edition) as the primary code and the International SNOMED CT substance as a secondary code. Used in cross-border dispensing scenario.

Atorvastatin 20mg film-coated tablets (generic), coded with the NMPC VMP (SNOMED CT Irish Edition) as the primary code and the International SNOMED CT substance as a secondary code.

The product prescribed in ie-rx-be-atorvastatin-neps. The NMPC code is the NMPC VMP (SNOMED CT Irish Edition), verified in the NMPC Meds Catalogue.

The product actually dispensed in ie-dispense-be-to-ie-neps. HL7 Europe MPD requires a dispense to reference a Medication resource.

Atorvastatin 80mg film-coated tablets (high-intensity statin). The NMPC VMP code (SNOMED CT Irish Edition) is primary, the International SNOMED CT substance is secondary, and ATC code C10AA05 is included for classification.

Insulin aspart 100 units/ml solution for injection, rapid-acting insulin. The NMPC VMP code (SNOMED CT Irish Edition) is primary, the International SNOMED CT substance is secondary, and ATC code A10AB05 is included for classification.

Insulin glargine 100 units/ml solution for injection, long-acting basal insulin. The NMPC VMP code (SNOMED CT Irish Edition) is primary, the International SNOMED CT substance is secondary, and ATC code A10AE04 is included for classification.

Lisinopril 10mg tablets, ACE inhibitor for hypertension. The NMPC VMP code (SNOMED CT Irish Edition) is primary, the International SNOMED CT substance is secondary, and ATC code C09AA03 is included for classification.

The product actually dispensed in ie-dispense-de-lisinopril. HL7 Europe MPD requires a dispense to reference a Medication resource.

The product actually dispensed in ie-dispense-de-metformin. HL7 Europe MPD requires a dispense to reference a Medication resource.

Metformin hydrochloride 500mg film-coated tablets (generic), coded with the NMPC VMP (SNOMED CT Irish Edition) as the primary code and the International SNOMED CT substance as a secondary code.

The product actually dispensed in ie-dispense-fi-to-ie-neps. HL7 Europe MPD requires a dispense to reference a Medication resource.

The product actually dispensed in ie-dispense-lv-metformin. HL7 Europe MPD requires a dispense to reference a Medication resource.

Omeprazole 20mg gastro-resistant capsules, proton pump inhibitor. The NMPC VMP code (SNOMED CT Irish Edition) is primary, the International SNOMED CT substance is secondary, and ATC code A02BC01 is included for classification.

Ramipril 10mg capsules, ACE inhibitor. The NMPC VMP code (SNOMED CT Irish Edition) is primary, the International SNOMED CT substance is secondary, and ATC code C09AA05 is included for classification.

Ramipril 5mg capsules (generic), coded with the NMPC VMP (SNOMED CT Irish Edition) as the primary code and the International SNOMED CT substance as a secondary code.

The product actually dispensed in ie-dispense-pt-sertraline. HL7 Europe MPD requires a dispense to reference a Medication resource.

Sertraline hydrochloride 50mg tablets, SSRI antidepressant. The NMPC VMP code (SNOMED CT Irish Edition) is primary, the International SNOMED CT substance is secondary, and ATC code N06AB06 is included for classification.

Warfarin sodium 5mg tablets, anticoagulant. The NMPC VMP code (SNOMED CT Irish Edition) is primary, the International SNOMED CT substance is secondary, and ATC code B01AA03 is included for classification. Requires INR monitoring.

Grafton Street Medical Practice, Dublin 2 — GP practice from which Seán Murphy's prescriptions are issued.

Belgian patient Lars Janssen visiting Dublin. His Belgian prescription for Atorvastatin 40mg is dispensed at McCauley's Pharmacy via NePS.

Finnish patient Mikko Korhonen visiting Dublin. His Finnish prescription for Metformin 500mg is dispensed at Hickey's Pharmacy, O'Connell Street via NePS.

Seán Patrick Murphy, an Irish patient with Type 2 Diabetes, Essential Hypertension, and Hypercholesterolaemia. Carries an Irish PPS number, IHI, medical card number and eIDAS identity used in cross-border ePrescription exchange via MyHealth@EU.

Swedish pharmacy in Stockholm where Seán Murphy's Irish ePrescription for insulin was dispensed (10 July 2025).

Danish pharmacy in Copenhagen where Seán Murphy's Irish ePrescription for Warfarin 5mg was dispensed (1 July 2025).

German pharmacy in Berlin where Seán Murphy's Irish ePrescription for Metformin and Lisinopril was dispensed on 20 January 2025.

Austrian pharmacy in Vienna where Seán Murphy's Irish ePrescription was dispensed (15 July 2025).

Portuguese pharmacy in Lisbon where Seán Murphy's Irish ePrescription for Sertraline and Omeprazole was dispensed (20 June 2025).

Irish community pharmacy dispensing a Finnish cross-border prescription for Mikko Korhonen via NePS.

Irish community pharmacy dispensing a Belgian cross-border prescription for Lars Janssen via NePS.

Latvian pharmacy in Riga where Seán Murphy's Irish ePrescription was dispensed (15 June 2025).

Dr. Aoife O'Brien, General Practitioner at Grafton Street Medical Practice, Dublin. Prescribing physician for Seán Murphy's cross-border prescriptions.

German pharmacy dispensation of Lisinopril 10mg Tabletten (Hexal, PZN 03990693) against the Irish cross-border ePrescription. Generic substitution performed.

German pharmacy dispensation of Metformin 500mg Filmtabletten (Ratiopharm, PZN 04823246) against the Irish cross-border ePrescription. Generic substitution performed.

Irish ePrescription for Lisinopril 10mg for Seán Murphy, transmitted via MyHealth@EU to Germany.

Irish ePrescription for Metformin 500mg for Seán Murphy, transmitted via MyHealth@EU to Germany. Carries PCRS identifier and eIDAS cross-border identifier.

Single-item acute prescription (HIQA EP Section 3).

Completed dispensation (HIQA EP Section 6) handed to the patient.

Who dispensed scenario 1, on behalf of which pharmacy, and when: carried in the ePG with the eDispensation it describes (ADR-003).

HIQA EP: patient, prescriber, facility, medicinal product, allergy statement (nilknown) and one prescription item.

Full dispensation of 60 Metformin 500mg tablets against Scenario 1 prescription. Dispensed in full at Boots Pharmacy Dublin.

A standard Irish GP prescription for Metformin 500mg tablets. Authorised via PCRS. Intended for a single full dispensation.

HIQA EP Section 3 for scenario 1: identifier (3.1), date of issue (3.2), group status active (3.3) and its one eP (3.5).

Finnish ePrescription for Metformin 500mg for Mikko Korhonen, received via NePS for cross-border dispensation in Ireland.

Hickey's Pharmacy, Dublin dispenses Metformin 500mg for Finnish patient Mikko Korhonen against a Finnish prescription received via NePS. The Finnish medication code (Kela/FIN) is mapped to an Irish NMPC code.

The prescription after cancellation: the group is revoked with a reason and its eP is cancelled with a reason.

The whole prescription is cancelled: status revoked with the reason (HIQA EP 3.3.1 to 3.3.3; ie-grp-status-1). Its only eP is cancelled, so the statuses agree (ie-bnd-rx-10).

The prescriber cancels the prescription before dispensing because the treatment is changed. The item is cancelled with a reason (HIQA EP 3.5.2.1 to 3.5.2.3; ie-rx-status-1).

Belgian ePrescription for Atorvastatin 40mg for Lars Janssen, received via NePS for cross-border dispensation in Ireland.

McCauley's Pharmacy, Dublin dispenses Atorvastatin 40mg for Belgian patient Lars Janssen against a Belgian prescription received via NePS. Belgian CNPV medication code is mapped to an Irish NMPC code.

HIQA EP 1.6.3 Weight: supports weight-based paediatric dosing.

Enforces the legal requirement to state the age of a child under 12 (ie-bnd-rx-3).

An Irish GP prescription for Atorvastatin 20mg tablets (90 days supply). Intended to be dispensed in three partial dispensations of 30 tablets each, reflecting typical Irish community pharmacy dispensing for long-term medication.

The patient is 5 years old: the age at prescribing is recorded (HIQA EP 1.4.2; legal requirement under 12; invariants ie-rx-age-1 and ie-bnd-rx-3). The weight is referenced as supporting information (EP 1.6.3).

First partial dispensation of 30 Atorvastatin 20mg tablets (of 90 prescribed) on 15 June 2024.

Second partial dispensation of 30 Atorvastatin 20mg tablets on 15 July 2024.

Third and final partial dispensation of 30 Atorvastatin 20mg tablets on 15 August 2024. Completes the full 90-tablet prescription.

HIQA EP Section 3 for scenario 2.

First supply, part filled because of stock (v3-ActCode FFP).

Completes the first supply (v3-ActCode FFC).

First repeat, after the minimum dispense interval (v3-ActCode RF). Repeats dispensed so far: 1 of 5 (derived).

The allergy statement lists a confirmed penicillin allergy (EP 1.6.2).

Full dispensation of Atorvastatin 30 tablets from the multi-prescription bundle.

Full dispensation of Metformin 60 tablets from the multi-prescription bundle.

Full dispensation of Ramipril 28 capsules from the multi-prescription bundle.

Second of three prescriptions in a multi-prescription bundle for John Murphy. Atorvastatin for hyperlipidaemia.

First of three prescriptions in a multi-prescription bundle for John Murphy. Metformin for Type 2 Diabetes.

Third of three prescriptions in a multi-prescription bundle for John Murphy. Ramipril for hypertension/cardiac protection.

HIQA EP Section 3 for scenario 3. The prescription stays active while repeats remain.

Continuous therapy with repeats (HIQA EP 3.5.11), a minimum dispense interval (EP 3.5.13) and the overall prescribed quantity (EP 3.5.7.1). Repeats already dispensed are derived from the MedicationDispense records (IE Core ADR-003).

Misuse of Drugs Regulations 2017 requirements as cited by HIQA: quantity in words and figures (EP 3.5.7.2), number of instalments (EP 3.5.12) and validity of no more than 14 days (EP 3.5.9.1). Invariants ie-rx-cd-1 and ie-rx-cd-2. 'Do Not Substitute' with a reason (EP 3.5.10.2/3).

An Irish ePrescription for Amlodipine 5mg (chronic hypertension, repeat prescription) issued by an Irish GP. This prescription is transmitted via the MyHealth@EU infrastructure (IE NCP → ES NCP) for dispensation at a Spanish pharmacy. The prescription is tagged as cross-border eligible.

A Spanish pharmacy dispenses Amlodipine 5mg (30 tablets) against the Irish cross-border ePrescription for Ciarán Walsh, via MyHealth@EU. The Spanish pharmacist substituted with a locally available generic equivalent (Norvasc generic, ES market).

First instalment of a Schedule 2 controlled drug.

Schedule 2 controlled-drug prescription.

HIQA EP Section 3 for scenario 4, with a rendered copy of the prescription as its presented form (HIQA EP 3.4; plain text here for brevity, typically a PDF).

Latvian pharmacy dispensation of Metformins 500mg tabletes (ZRA code ZRA-00098432) against the Irish cross-border ePrescription.

Irish ePrescription for Metformin 500mg for Seán Murphy, transmitted via MyHealth@EU to Latvia.

An Irish pharmacy (Boots, Grafton St.) dispenses Amlodipine 5mg tablets against the Spanish cross-border ePrescription for María García López, via MyHealth@EU. Equivalent Irish-licensed generic dispensed.

A Spanish ePrescription for Amlodipine 5mg issued by a Spanish GP for María García López. This prescription has been converted to FHIR format by the Spanish NCP (Punto de Contacto Nacional) for cross-border dispensation in Ireland via MyHealth@EU.

The prescription as sent. The declined dispense is hiqa-md-s5-declined.

HIQA EP 6.3.1 status (declined) and 6.3.2.2 reason (free text); invariant ie-md-status-1. No medication is handed over, so the dispensed quantity (EP 6.7, Mandatory) is zero.

HIQA EP Section 3 for scenario 5. The prescription itself stays active; the non-dispensation is recorded on the MedicationDispense.

The allergy statement sent with the prescription records a penicillin allergy. The pharmacist declines to dispense (scenario 5).

Portuguese pharmacy dispensation of Sertralina 50mg Comprimidos (INFARMED code INF-00012345).

Irish ePrescription for Sertraline 50mg for Seán Murphy, transmitted via MyHealth@EU to Portugal.

Claims IEMpdElectronicPrescriptionGroupCrossBorder (no invented tag; IE Core ADR-003): patient date of birth, prescriber telephone and secure email (EP 2.10.1/2.10.2; ie-bnd-xb-1) and a signature covering every item (EP 2.13; ie-bnd-xb-2).

Item 1 of a two-item prescription to be dispensed in another EU Member State.

Item 2 of the cross-border prescription; same group identifier (EP 3.1).

HIQA EP 2.13 Signature. The signature value is a SYNTHETIC placeholder, not a real signature. The format (e.g. JAdES) and eIDAS assurance level are Requires Clarification (IE Core OI-009).

HIQA EP Section 3 for scenario 6: two electronic prescriptions (eP) issued together, sharing the prescription group identifier (HIQA EP 3.1).

First monthly dispensation of Metformin under the 6-month GMS repeat prescription.

Second monthly dispensation of Metformin under the 6-month GMS repeat prescription.

Third monthly dispensation of Metformin under the 6-month GMS repeat prescription.

A GMS repeat prescription for Metformin 500mg tablets, valid for 6 months with up to 6 dispensation events (once monthly). Represents a typical Irish GMS chronic disease management prescription under the Drugs Payment Scheme.

Irish ePrescription for Warfarin 5mg for Seán Murphy, transmitted via MyHealth@EU to Denmark. Includes critical INR monitoring note.

Dr Nolan supervises two puffs of salbutamol during an asthma review. IE-defined (HIQA's EP draft does not cover administration).

Irish ePrescription for Insulin Glargine 100u/ml for Seán Murphy, transmitted via MyHealth@EU to Sweden.

A scheduled dose recorded as not given, with the reason (invariant ie-mad-status-1).

Irish ePrescription for Atorvastatin 80mg for Seán Murphy, transmitted via MyHealth@EU to Austria.

What the patient reports taking (HIQA PS 6.3), recorded by her GP.

The Spanish primary care centre where the Spanish GP practises and issued the cross-border prescription.

A Spanish patient visiting Ireland. Carries a Spanish CIP identifier and European Health Insurance Card (EHIC). Holds a prescription from a Spanish GP to be dispensed in Ireland.

A Spanish pharmacist dispensing a cross-border prescription from Ireland (Scenario 4: IE→ES).

A Spanish community pharmacy in Madrid that dispenses a cross-border prescription for an Irish patient traveling in Spain.

A Spanish GP who issued a prescription for a Spanish patient, to be dispensed cross-border in Ireland via MyHealth@EU.

Four continuous electronic prescriptions issued together at a GP review: amlodipine, ramipril, atorvastatin (at night) and metformin (with food), each with 5 repeats. Two of the four have been dispensed so far, so the group is active with a mix of dispensed and not-yet-dispensed eP. Product-based doses use SNOMED CT units of presentation.

Group-level data (HIQA EP 3.1 to 3.5) for ePG 11: 4 electronic prescriptions issued together.

First supply of eP 1 (28 tablets).

First supply of eP 4 (56 tablets).

Amlodipine 5 mg (NMPC VMP 267451000220105, ATC C08CA01) for essential hypertension: continuous, 28-day supply, 5 repeats.

Ramipril 5 mg capsules (NMPC VMP 716371000220101) for essential hypertension.

Atorvastatin 20 mg (NMPC VMP 254311000220102) for hypercholesterolaemia, taken at bedtime (timing.repeat.when HS).

A basal-bolus insulin regimen as two electronic prescriptions issued together: insulin glargine once a day at bedtime and insulin aspart with each meal (three concurrent dosages with sequence 1). Doses in UCUM international units; supply in SNOMED CT units of presentation (Pen, Cartridge).

Group-level data (HIQA EP 3.1 to 3.5) for ePG 12: 2 electronic prescriptions issued together.

Group-level data (HIQA EP 3.1 to 3.5) for ePG 13: 2 electronic prescriptions issued together.

Sertraline 50 mg (NMPC VMP 268301000220104) for depression, taken in the morning (timing.repeat.when MORN); substitution not allowed, with the reason (HIQA EP 3.5.10.2, 3.5.10.3).

Omeprazole 20 mg gastro-resistant capsules (NMPC VMP 313941000220100) for gastro-oesophageal reflux disease, before breakfast (ACM).

Two electronic prescriptions issued together: warfarin with two consecutive dosage schemes (sequence 1 loading for 2 days, sequence 2 maintenance) and lisinopril once a day.

Group-level data (HIQA EP 3.1 to 3.5) for ePG 14: 2 electronic prescriptions issued together.

Warfarin 5 mg (NMPC VMP 718731000220101) for atrial fibrillation: sequence 1, two tablets once a day for 2 days; sequence 2, one tablet once a day as directed by the anticoagulation clinic.

Lisinopril 10 mg (NMPC VMP 714701000220101, ATC C09AA03) for hypertensive disorder.

Two electronic prescriptions issued together for a 5-year-old (age at prescribing recorded on each eP, HIQA EP 1.4.2): amoxicillin suspension dosed in mL for 5 days, and a salbutamol inhaler as needed with a dose range and a maximum dose.

Group-level data (HIQA EP 3.1 to 3.5) for ePG 15: 2 electronic prescriptions issued together.

Salbutamol 100 micrograms/actuation inhaler (NMPC VMP 363291000220101) for asthma: as needed (asNeededBoolean, HL7 Europe MPD), dose range 1 to 2 actuations, at most 8 in 24 hours; supply of 200 actuations.